![Praxis Precision Medicines, Inc. logo](/logos/PRAX.webp)
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
Overview | Financials
Company Name | Praxis Precision Medicines, Inc. |
Symbol | PRAX |
Currency | USD |
Price | 54.02 |
Market Cap | 959,238,542 |
Dividend Yield | 0% |
52-week-range | 13.005 - 67.21 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Marcio Souza M.B.A. |
Website | https://www.praxismedicines.com |
An error occurred while fetching data.
About Praxis Precision Medicines, Inc.
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of major depressive disorder and perimenopausal depression; and
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD